{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T02:16:35Z","timestamp":1774404995700,"version":"3.50.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-025-01457-z","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:17:52Z","timestamp":1765268272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Headache After Stroke: An Update for the Clinician"],"prefix":"10.1007","volume":"25","author":[{"given":"James JH.","family":"Im","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William S.","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"1","key":"1457_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202.","journal-title":"Cephalalgia"},{"issue":"1","key":"1457_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01372-x","volume":"23","author":"ER Lebedeva","year":"2022","unstructured":"Lebedeva ER, Ushenin AV, Gurary NM, Gilev DV, Olesen J. Diagnostic criteria for acute headache attributed to ischemic stroke and for sentinel headache before ischemic stroke. J Headache Pain. 2022;23(1):11. https:\/\/doi.org\/10.1186\/s10194-021-01372-x.","journal-title":"J Headache Pain"},{"issue":"11","key":"1457_CR3","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11916-023-01169-4","volume":"27","author":"M Chan","year":"2023","unstructured":"Chan M, Thaler A. Post-stroke headache. Curr Pain Headache Rep. 2023;27(11):673\u20138. https:\/\/doi.org\/10.1007\/s11916-023-01169-4.","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"1457_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1186\/s12889-022-13917-z","volume":"22","author":"Q Xie","year":"2022","unstructured":"Xie Q, Wu Y, Pei J, Gao Q, Guo Q, Wang X, et al. Prevalence and risk factors of ischemic stroke-related headache in China: a systematic review and meta-analysis. BMC Public Health. 2022;22(1):1533. https:\/\/doi.org\/10.1186\/s12889-022-13917-z.","journal-title":"BMC Public Health"},{"issue":"03","key":"1457_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-0043-1763487","volume":"81","author":"FAAD Oliveira","year":"2023","unstructured":"Oliveira FAAD, Dourado-Filho MG, Rocha-Filho PAS. Acute headache attributed to ischemic stroke: assessment of its characteristics and associated factors. Arq Neuropsiquiatr. 2023;81(03):225\u201332. https:\/\/doi.org\/10.1055\/s-0043-1763487.","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"1457_CR6","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/head.13478","volume":"59","author":"FAA Oliveira","year":"2019","unstructured":"Oliveira FAA, Sampaio Rocha-Filho PA. Headaches attributed to ischemic stroke and transient ischemic attack. Headache. 2019;59(3):469\u201376. https:\/\/doi.org\/10.1111\/head.13478.","journal-title":"Headache"},{"key":"1457_CR7","volume-title":"Mechanisms of vascular disease: a reference book for vascular specialists","year":"2011","unstructured":"Fitridge R, Thompson M, editors. Mechanisms of vascular disease: a reference book for vascular specialists. Adelaide (AU): University of Adelaide Press; 2011. cited 2025 Apr 20]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534260\/"},{"issue":"1","key":"1457_CR8","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/brain\/awv333","volume":"139","author":"CL Seifert","year":"2016","unstructured":"Seifert CL, Sch\u00f6nbach EM, Magon S, Gross E, Zimmer C, F\u00f6rschler A, et al. Headache in acute ischaemic stroke: a lesion mapping study. Brain. 2016;139(1):217\u201326. https:\/\/doi.org\/10.1093\/brain\/awv333.","journal-title":"Brain"},{"issue":"2","key":"1457_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0143-4179(98)90035-X","volume":"32","author":"V Bucinskaite","year":"1998","unstructured":"Bucinskaite V, Brodda-Jansen G, Stenfors C, Theodorsson E, Lundeberg T. Increased concentrations of calcitonin gene-related peptide-like immunoreactivity in rat brain and peripheral tissue after ischaemia: correlation to flap survival. Neuropeptides. 1998;32(2):179\u201383. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014341799890035X","journal-title":"Neuropeptides"},{"key":"1457_CR10","doi-asserted-by":"publisher","first-page":"1184766","DOI":"10.3389\/fnins.2023.1184766\/full","volume":"17","author":"J Xiong","year":"2023","unstructured":"Xiong J, Wang Z, Bai J, Cheng K, Liu Q, Ni J. Calcitonin gene-related peptide: a potential protective agent in cerebral ischemia\u2013reperfusion injury. Front Neurosci. 2023;17:1184766. https:\/\/doi.org\/10.3389\/fnins.2023.1184766\/full.","journal-title":"Front Neurosci"},{"issue":"11","key":"1457_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-1003-2","volume":"19","author":"AR Plecash","year":"2019","unstructured":"Plecash AR, Chebini A, Ip A, Lai JJ, Mattar AA, Randhawa J, et al. Updates in the treatment of post-stroke pain. Curr Neurol Neurosci Rep. 2019;19(11):86. https:\/\/doi.org\/10.1007\/s11910-019-1003-2.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"1457_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10194-022-01479-9","volume":"23","author":"ER Lebedeva","year":"2022","unstructured":"Lebedeva ER, Ushenin AV, Gurary NM, Gilev DV, Kislyak NV, Olesen J. Persistent headache after first-ever ischemic stroke: clinical characteristics and factors associated with its development. J Headache Pain. 2022;23(1):103. https:\/\/doi.org\/10.1186\/s10194-022-01479-9.","journal-title":"J Headache Pain"},{"issue":"12","key":"1457_CR13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s11916-023-01181-8","volume":"28","author":"D Pomar-Forero","year":"2024","unstructured":"Pomar-Forero D, Ahmad B, Barlow B, Busl KM, Maciel CB. Headache management in the neuroscience intensive care unit. Curr Pain Headache Rep. 2024;28(12):1273\u201387. https:\/\/doi.org\/10.1007\/s11916-023-01181-8.","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"1457_CR14","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/head.12908","volume":"56","author":"AH Morad","year":"2016","unstructured":"Morad AH, Tamargo RJ, Gottschalk A. The longitudinal course of pain and analgesic therapy following aneurysmal subarachnoid hemorrhage: a cohort study. Headache. 2016;56(10):1617\u201325. https:\/\/doi.org\/10.1111\/head.12908.","journal-title":"Headache"},{"key":"1457_CR15","doi-asserted-by":"crossref","unstructured":"Klavansky D, Wanchoo S, Lin A, Temes RE, Rebeiz T. Predictors of opiate utilization in the treatment of headache and impact on three-month outcomes following subarachnoid hemorrhage. Cureus. 2021; [cited 2025 Mar 23]; Available from: https:\/\/www.cureus.com\/articles\/71231-predictors-of-opiate-utilization-in-the-treatment-of-headache-and-impact-on-three-month-outcomes-following-subarachnoid-hemorrhage","DOI":"10.7759\/cureus.20773"},{"key":"1457_CR16","doi-asserted-by":"publisher","first-page":"106286","DOI":"10.1016\/j.eplepsyres.2020.106286","volume":"161","author":"JP Z\u00f6llner","year":"2020","unstructured":"Z\u00f6llner JP, Konczalla J, Stein M, Roth C, Krakow K, Kaps M, et al. Acute symptomatic seizures in intracerebral and subarachnoid hemorrhage: a population study of 19,331 patients. Epilepsy Res. 2020;161:106286. Cited 2025 Apr 20.Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092012111930542X","journal-title":"Epilepsy Res"},{"issue":"4","key":"1457_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.inat.2014.07.003","volume":"1","author":"R Swope","year":"2014","unstructured":"Swope R, Glover K, Gokun Y, Fraser JF, Cook AM. Evaluation of headache severity after aneurysmal subarachnoid hemorrhage. Interdiscip Neurosurg. 2014;1(4):119\u201322. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214751914000334","journal-title":"Interdiscip Neurosurg"},{"key":"1457_CR18","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jocn.2023.07.023","volume":"115","author":"ZA Sorrentino","year":"2023","unstructured":"Sorrentino ZA, Desai A, Eisinger RS, Maciel CB, Busl KM, Lucke-Wold B. Evaluating analgesic medications utilized in the treatment of aneurysmal subarachnoid hemorrhage and association with delayed cerebral ischemia. J Clin Neurosci. 2023;115:157\u201362. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586823001960","journal-title":"J Clin Neurosci"},{"issue":"4","key":"1457_CR19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00701-020-04235-7","volume":"162","author":"T Huckhagel","year":"2020","unstructured":"Huckhagel T, Klinger R, Schmidt NO, Regelsberger J, Westphal M, Czorlich P. The burden of headache following aneurysmal subarachnoid hemorrhage: a prospective single-center cross-sectional analysis. Acta Neurochir. 2020;162(4):893\u2013903. https:\/\/doi.org\/10.1007\/s00701-020-04235-7.","journal-title":"Acta Neurochir"},{"issue":"7","key":"1457_CR20","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/head.12612","volume":"55","author":"C Hong","year":"2015","unstructured":"Hong C, Joo J, Kim YB, Shim YS, Lim YC, Shin YS, et al. The course of headache in patients with moderate-to-severe headache due to aneurysmal subarachnoid hemorrhage: a retrospective cross-sectional study. Headache. 2015;55(7):992\u20139. https:\/\/doi.org\/10.1111\/head.12612.","journal-title":"Headache"},{"key":"1457_CR21","doi-asserted-by":"publisher","first-page":"107355","DOI":"10.1016\/j.clineuro.2022.107355","volume":"220","author":"Y Mehkri","year":"2022","unstructured":"Mehkri Y, Hanna C, Sriram S, Lucke-Wold B, Johnson RD, Busl K. Calcitonin gene-related peptide and neurologic injury: an emerging target for headache management. Clin Neurol Neurosurg. 2022;220:107355. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722002360","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"1457_CR22","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1007\/s11064-020-03141-9","volume":"45","author":"J Tian","year":"2020","unstructured":"Tian J, Yang L, Wang P, Yang L, Fan Z. Exogenous CGRP regulates apoptosis and autophagy to alleviate traumatic brain injury through Akt\/mTOR signalling pathway. Neurochem Res. 2020;45(12):2926\u201338. https:\/\/doi.org\/10.1007\/s11064-020-03141-9.","journal-title":"Neurochem Res"},{"issue":"2","key":"1457_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/head.14884","volume":"65","author":"A Gandhi","year":"2025","unstructured":"Gandhi A, Quinoa TR, Geller E, Khandelwal P, Agarwalla PK. Erenumab in a patient with persistent headaches after subarachnoid hemorrhage: a case report of an effective treatment. Headache. 2025;65(2):373\u20136. https:\/\/doi.org\/10.1111\/head.14884.","journal-title":"Headache"},{"key":"1457_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.889213","volume":"13","author":"E Br\u00fcndl","year":"2022","unstructured":"Br\u00fcndl E, Proescholdt M, St\u00f6rr EM, Sch\u00f6del P, Bele S, Zeman F, et al. The endogenous neuropeptide calcitonin gene-related peptide after spontaneous subarachnoid hemorrhage-a potential psychoactive prognostic serum biomarker of pain-associated neuropsychological symptoms. Front Neurol. 2022;13:889213.","journal-title":"Front Neurol"},{"issue":"11","key":"1457_CR25","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.mayocp.2024.03.023","volume":"99","author":"Z Wang","year":"2024","unstructured":"Wang Z, VanderPluym JH, Halker Singh RB, Alsibai RA, Roellinger DL, Firwana M, et al. Safety of triptans in patients who have or are at high risk for cardiovascular disease. Mayo Clin Proc. 2024;99(11):1722\u201331. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619624001642","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"1457_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/87551225211024630","volume":"37","author":"JK Beauchene","year":"2021","unstructured":"Beauchene JK, Levien TL. Lasmiditan: acute migraine treatment without vasoconstriction. A review. J Pharm Technol. 2021;37(5):244\u201353. https:\/\/doi.org\/10.1177\/87551225211024630.","journal-title":"J Pharm Technol"},{"issue":"1","key":"1457_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10194-020-01132-3","volume":"21","author":"DB Clemow","year":"2020","unstructured":"Clemow DB, Johnson KW, Hochstetler HM, Ossipov MH, Hake AM, Blumenfeld AM. Lasmiditan mechanism of action \u2013 review of a selective 5-HT1F agonist. J Headache Pain. 2020;21(1):71. https:\/\/doi.org\/10.1186\/s10194-020-01132-3.","journal-title":"J Headache Pain"},{"issue":"2","key":"1457_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12028-022-01571-7","volume":"38","author":"CB Maciel","year":"2023","unstructured":"Maciel CB, Barlow B, Lucke-Wold B, Gobinathan A, Abu-Mowis Z, Peethala MM, et al. Acute headache management for patients with subarachnoid hemorrhage: an international survey of health care providers. Neurocrit Care. 2023;38(2):395\u2013406. https:\/\/doi.org\/10.1007\/s12028-022-01571-7.","journal-title":"Neurocrit Care"},{"issue":"1","key":"1457_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0333102412467512","volume":"33","author":"JL Johnson","year":"2013","unstructured":"Johnson JL, Hutchinson MR, Williams DB, Rolan P. Medication-overuse headache and opioid-induced hyperalgesia: a review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment. Cephalalgia. 2013;33(1):52\u201364. https:\/\/doi.org\/10.1177\/0333102412467512.","journal-title":"Cephalalgia"},{"issue":"10","key":"1457_CR30","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/phar.2169","volume":"38","author":"R Dagenais","year":"2018","unstructured":"Dagenais R, Zed PJ. Intranasal lidocaine for acute management of primary headaches: a systematic review. Pharmacother J Hum Pharmacol Drug Ther. 2018;38(10):1038\u201350. https:\/\/doi.org\/10.1002\/phar.2169.","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"8","key":"1457_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1310\/hpj5108-662","volume":"51","author":"DL Moellentin","year":"2016","unstructured":"Moellentin DL, Stewart D, Barbour J. Case study of fatal stroke following intranasal lidocaine. Hosp Pharm. 2016;51(8):662\u20134.","journal-title":"Hosp Pharm"},{"issue":"6","key":"1457_CR32","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231183166","volume":"43","author":"C Carcel","year":"2023","unstructured":"Carcel C, Haghdoost F, Shen J, Nanda P, Bai Y, Atkins E, et al. The effect of blood pressure lowering medications on the prevention of episodic migraine: a systematic review and meta-analysis. Cephalalgia. 2023;43(6):03331024231183166. https:\/\/doi.org\/10.1177\/03331024231183166.","journal-title":"Cephalalgia"},{"issue":"1","key":"1457_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02226-3","volume":"30","author":"C Wang","year":"2025","unstructured":"Wang C, Feng L, Tu S, Wei D, Wang R, Deng Z, et al. Antihypertensive strategies for the prevention of secondary stroke: a systematic review and meta-analysis. Eur J Med Res. 2025;30(1):18. https:\/\/doi.org\/10.1186\/s40001-024-02226-3.","journal-title":"Eur J Med Res"},{"key":"1457_CR34","doi-asserted-by":"publisher","unstructured":"Winstein CJ, Stein J, Arena R, Bates B, Cherney LR, Cramer SC, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2016;47(6) https:\/\/doi.org\/10.1161\/STR.0000000000000098.","DOI":"10.1161\/STR.0000000000000098"},{"issue":"21","key":"1457_CR35","doi-asserted-by":"publisher","first-page":"11685","DOI":"10.3390\/ijms252111685","volume":"25","author":"MT Eller","year":"2024","unstructured":"Eller MT, Frank F, Kaltseis K, Karisik A, Knoflach M, Broessner G. Novel Calcitonin Gene-Related Peptide (CGRP) interfering migraine therapies and stroke\u2014a review. Int J Mol Sci. 2024;25(21):11685. Cited 2025 Apr 20. Available from: https:\/\/www.mdpi.com\/1422-0067\/25\/21\/11685","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1457_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01470-4","volume":"23","author":"C Lampl","year":"2022","unstructured":"Lampl C, Kraus V, Lehner K, Loop B, Chehrenama M, Maczynska Z, et al. Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials. J Headache Pain. 2022;23(1):104. https:\/\/doi.org\/10.1186\/s10194-022-01470-4.","journal-title":"J Headache Pain"},{"issue":"3","key":"1457_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231152169","volume":"43","author":"R Messina","year":"2023","unstructured":"Messina R, Huessler EM, Puledda F, Haghdoost F, Lebedeva ER, Diener HC. Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: a systematic review and network meta-analysis. Cephalalgia. 2023;43(3):03331024231152169. https:\/\/doi.org\/10.1177\/03331024231152169.","journal-title":"Cephalalgia"},{"issue":"14","key":"1457_CR38","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1177\/0333102419867282","volume":"39","author":"L Ohlsson","year":"2019","unstructured":"Ohlsson L, Haanes KA, Kronvall E, Xu C, Snellman J, Edvinsson L. Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries. Cephalalgia. 2019;39(14):1745\u201352. https:\/\/doi.org\/10.1177\/0333102419867282.","journal-title":"Cephalalgia"},{"issue":"2","key":"1457_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/jamaneurol.2024.4537","volume":"82","author":"S Yang","year":"2025","unstructured":"Yang S, Orlova Y, Park H, Smith SM, Guo Y, Chapin BA, et al. Cardiovascular safety of anti-CGRP monoclonal antibodies in older adults or adults with disability with migraine. JAMA Neurol. 2025;82(2):132. Cited 2025 Apr 20. Available from: https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2828333","journal-title":"JAMA Neurol"},{"issue":"10","key":"1457_CR40","doi-asserted-by":"publisher","first-page":"104286","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.07.002","volume":"28","author":"S Aradi","year":"2019","unstructured":"Aradi S, Kaiser E, Cucchiara B. Ischemic stroke associated with calcitonin gene-related peptide inhibitor therapy for migraine: a case report. J Stroke Cerebrovasc Dis. 2019;28(10):104286. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305719303271","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"6","key":"1457_CR41","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s40122-024-00665-8","volume":"13","author":"T Asawavichienjinda","year":"2024","unstructured":"Asawavichienjinda T, Jittapiromsak N, Blumenfeld A. Cerebral artery vasoconstriction after galcanezumab loading dose for migraine prevention: a case report. Pain Ther. 2024;13(6):1705\u201312.","journal-title":"Pain Ther"},{"issue":"1","key":"1457_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01585-2","volume":"24","author":"A Mu\u00f1oz-Vendrell","year":"2023","unstructured":"Mu\u00f1oz-Vendrell A, Campoy S, Caronna E, Alpuente A, Torres-Ferrus M, Nieves Castellanos C, et al. Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients. J Headache Pain. 2023;24(1):63. https:\/\/doi.org\/10.1186\/s10194-023-01585-2.","journal-title":"J Headache Pain"},{"issue":"2","key":"1457_CR43","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/toxins12020127","volume":"12","author":"M Abo","year":"2020","unstructured":"Abo M, Shigematsu T, Hara H, Matsuda Y, Nimura A, Yamashita Y, et al. Efficacy and safety of onabotulinumtoxina 400 units in patients with post-stroke upper limb spasticity: final report of a randomized, double-blind, placebo-controlled trial with an open-label extension phase. Toxins. 2020;12(2):127. Cited 2025 Apr 20. Available from: https:\/\/www.mdpi.com\/2072-6651\/12\/2\/127","journal-title":"Toxins."},{"issue":"2","key":"1457_CR44","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1526-4610.2011.02052.x","volume":"52","author":"TW Ho","year":"2012","unstructured":"Ho TW, Ho AP, Chaitman BR, Johnson C, Mathew NT, Kost J, et al. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease. Headache. 2012;52(2):224\u201335. https:\/\/doi.org\/10.1111\/j.1526-4610.2011.02052.x.","journal-title":"Headache"},{"issue":"4","key":"1457_CR45","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ana.25831","volume":"88","author":"IA Mulder","year":"2020","unstructured":"Mulder IA, Li M, De Vries T, Qin T, Yanagisawa T, Sugimoto K, et al. Anti-migraine calcitonin gene\u2013related peptide receptor antagonists worsen cerebral ischemic outcome in mice. Ann Neurol. 2020;88(4):771\u201384. https:\/\/doi.org\/10.1002\/ana.25831.","journal-title":"Ann Neurol"},{"issue":"6","key":"1457_CR46","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.brs.2022.10.012","volume":"15","author":"EM Arsava","year":"2022","unstructured":"Arsava EM, Topcuoglu MA, Ay I, Ozdemir AO, Gungor IL, Togay Isikay C, et al. Assessment of safety and feasibility of non-invasive vagus nerve stimulation for treatment of acute stroke. Brain Stimulat. 2022;15(6):1467\u201374. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1935861X22002352","journal-title":"Brain Stimulat"},{"key":"1457_CR47","doi-asserted-by":"publisher","first-page":"1352145","DOI":"10.3389\/fneur.2024.1352145\/full","volume":"15","author":"L Qin","year":"2024","unstructured":"Qin L, Chen D, Li X, Gao Y, Xia W, Dai H, et al. Sphenopalatine ganglion stimulation: a comprehensive evaluation across diseases in randomized controlled trials. Front Neurol. 2024;15:1352145. https:\/\/doi.org\/10.3389\/fneur.2024.1352145\/full.","journal-title":"Front Neurol"},{"issue":"10194","key":"1457_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0140-6736(19)31192-4","volume":"394","author":"NM Bornstein","year":"2019","unstructured":"Bornstein NM, Saver JL, Diener HC, Gorelick PB, Shuaib A, Solberg Y, et al. An injectable implant to stimulate the sphenopalatine ganglion for treatment of acute ischaemic stroke up to 24 h from onset (ImpACT-24B): an international, randomised, double-blind, sham-controlled, pivotal trial. Lancet. 2019;394(10194):219\u201329. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673619311924","journal-title":"Lancet"},{"key":"1457_CR49","doi-asserted-by":"publisher","first-page":"100857","DOI":"10.1016\/j.inat.2020.100857","volume":"22","author":"GB Hile","year":"2020","unstructured":"Hile GB, Cook AM. Treatment of headache in aneurysmal subarachnoid hemorrhage: multimodal approach. Interdiscip Neurosurg. 2020;22:100857. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214751920304187","journal-title":"Interdiscip Neurosurg"},{"key":"1457_CR50","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/j.wneu.2019.10.062","volume":"134","author":"T Terakado","year":"2020","unstructured":"Terakado T, Nakai Y, Ikeda G, Uemura K, Matsumaru Y, Ishikawa E, et al. Effectiveness of low-dose intravenous fentanyl for postoperative headache management after neck clipping of ruptured intracranial aneurysms. World Neurosurg. 2020;134:e339\u201345. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875019326804","journal-title":"World Neurosurg"},{"issue":"3","key":"1457_CR51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/19418744231172350","volume":"13","author":"MN Jaffa","year":"2023","unstructured":"Jaffa MN, Podell JE, Foroutan A, Motta M, Chang WTW, Cherian J, et al. Steroids provide temporary improvement of refractory pain following subarachnoid hemorrhage. Neurohospitalist. 2023;13(3):236\u201342. https:\/\/doi.org\/10.1177\/19418744231172350.","journal-title":"Neurohospitalist"},{"issue":"2","key":"1457_CR52","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/head.13217","volume":"58","author":"A Von Luckner","year":"2018","unstructured":"Von Luckner A, Riederer F. Magnesium in migraine prophylaxis\u2014is there an evidence-based rationale? A systematic review. Headache J Head Face Pain. 2018;58(2):199\u2013209. https:\/\/doi.org\/10.1111\/head.13217.","journal-title":"Headache J Head Face Pain"},{"key":"1457_CR53","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/JPR.S132833","volume":"11","author":"A Negro","year":"2018","unstructured":"Negro A, Koverech A, Martelletti P. Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential. J Pain Res. 2018;11:515\u201326. Cited 2025 Apr 20. Available from: https:\/\/www.dovepress.com\/serotonin-receptor-agonists-in-the-acute-treatment-of-migraine-a-revie-peer-reviewed-article-JPR","journal-title":"J Pain Res"},{"issue":"3","key":"1457_CR54","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1468-2982.2006.00979.x","volume":"26","author":"K Pfadenhauer","year":"2006","unstructured":"Pfadenhauer K, Sch\u00f6nsteiner T, Keller H. The risks of sumatriptan administration in patients with unrecognized Subarachnoid Haemorrhage (SAH). Cephalalgia. 2006;26(3):320\u20133. https:\/\/doi.org\/10.1111\/j.1468-2982.2006.00979.x.","journal-title":"Cephalalgia"},{"issue":"3","key":"1457_CR55","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s12028-014-0086-5","volume":"22","author":"LP Dhakal","year":"2015","unstructured":"Dhakal LP, Hodge DO, Nagal J, Mayes M, Richie A, Ng LK, et al. Safety and tolerability of Gabapentin for aneurysmal subarachnoid hemorrhage (SAH) headache and meningismus. Neurocrit Care. 2015;22(3):414\u201321. https:\/\/doi.org\/10.1007\/s12028-014-0086-5.","journal-title":"Neurocrit Care"},{"key":"1457_CR56","doi-asserted-by":"publisher","first-page":"744","DOI":"10.3389\/fneur.2020.00744\/full","volume":"11","author":"LP Dhakal","year":"2020","unstructured":"Dhakal LP, Turnbull MT, Jackson DA, Edwards E, Hodge DO, Thottempudi N, et al. Safety, tolerability, and efficacy of pain reduction by gabapentin for acute headache and meningismus after aneurysmal subarachnoid hemorrhage: a pilot study. Front Neurol. 2020;11:744. https:\/\/doi.org\/10.3389\/fneur.2020.00744\/full.","journal-title":"Front Neurol"},{"key":"1457_CR57","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.wneu.2019.12.172","volume":"136","author":"J Koskim\u00e4ki","year":"2020","unstructured":"Koskim\u00e4ki J, Zhang D, Carri\u00f3n-Penagos J, Girard R, Piedad K, Polster SP, et al. Symptomatic brain hemorrhages from cavernous angioma after botulinum toxin injections, a role of TLR\/MEKK3 mechanism? Case report and review of the literature. World Neurosurg. 2020;136:7\u201311. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875019332048","journal-title":"World Neurosurg"},{"key":"1457_CR58","doi-asserted-by":"crossref","unstructured":"Do\u011fan R. Ultrasound-guided bilateral greater occipital nerve block on headache seen after endovascular treatment of ruptured or unruptured intracranial aneurysms. A case report. A\u011fr\u0131 J Turk Soc Algol. 2018;Cited 2025 Apr 20. Available from: http:\/\/www.agridergisi.com\/jvi.aspx?pdir=agri%26;plng=eng%26;un=AGRI-59023","DOI":"10.5505\/agri.2018.59023"},{"issue":"3","key":"1457_CR59","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/ANA.0000000000000523","volume":"31","author":"KB Venkatesulu","year":"2019","unstructured":"Venkatesulu KB, Nandhakumar A, Cherian M, Mehta P, Kalingarayar S, Shanmugam S. Scalp block for management of subarachnoid hemorrhage (SAH)-induced headache. J Neurosurg Anesthesiol. 2019;31(3):356\u20137. Cited 2025 Apr 20. Available from: https:\/\/journals.lww.com\/00008506-201907000-00021","journal-title":"J Neurosurg Anesthesiol"},{"key":"1457_CR60","doi-asserted-by":"publisher","first-page":"1122384","DOI":"10.3389\/fneur.2023.1122384\/full","volume":"14","author":"S Rajagopalan","year":"2023","unstructured":"Rajagopalan S, Siva N, Novak A, Garavaglia J, Jelsema C. Safety and efficacy of peripheral nerve blocks to treat refractory headaches after aneurysmal subarachnoid hemorrhage \u2013 a pilot observational study. Front Neurol. 2023;14:1122384. https:\/\/doi.org\/10.3389\/fneur.2023.1122384\/full.","journal-title":"Front Neurol"},{"issue":"1","key":"1457_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s12028-024-02078-z","volume":"42","author":"KM Busl","year":"2025","unstructured":"Busl KM, Smith CR, Troxel AB, Fava M, Illenberger N, Pop R, et al. Rationale and design for the BLOCK-SAH study (pterygopalatine fossa block as an opioid-sparing treatment for acute headache in aneurysmal subarachnoid hemorrhage): a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial with a sequential parallel comparison design. Neurocrit Care. 2025;42(1):290\u2013300. https:\/\/doi.org\/10.1007\/s12028-024-02078-z.","journal-title":"Neurocrit Care"},{"issue":"1","key":"1457_CR62","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s12028-020-01157-1","volume":"35","author":"CR Smith","year":"2021","unstructured":"Smith CR, Fox WC, Robinson CP, Garvan C, Babi MA, Pizzi MA, et al. Pterygopalatine fossa blockade as novel, narcotic-sparing treatment for headache in patients with spontaneous subarachnoid hemorrhage. Neurocrit Care. 2021;35(1):241\u20138. https:\/\/doi.org\/10.1007\/s12028-020-01157-1.","journal-title":"Neurocrit Care"},{"issue":"10","key":"1457_CR63","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.3390\/ijerph20105836","volume":"20","author":"P Rigoard","year":"2023","unstructured":"Rigoard P, Billot M, Moens M, Goudman L, El-Hajj H, Ingrand P, et al. Evaluation of external trigeminal nerve stimulation to prevent cerebral vasospasm after subarachnoid hemorrhage due to aneurysmal rupture: a randomized, double-blind proof-of-concept pilot trial (TRIVASOSTIM study). Int J Environ Res Public Health. 2023;20(10):5836. Cited 2025 Apr 20. Available from: https:\/\/www.mdpi.com\/1660-4601\/20\/10\/5836","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"1457_CR64","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000001576","volume":"16","author":"F Salgado","year":"2022","unstructured":"Salgado F, Douangpraseuth S, Dickerson JR, Crowley JW, Newton FA. Lidocaine infusion for the treatment of headache associated with subarachnoid hemorrhage: a case report. AA Pract. 2022;16(3):e01576. https:\/\/doi.org\/10.1213\/XAA.0000000000001576.","journal-title":"AA Pract"},{"key":"1457_CR65","doi-asserted-by":"publisher","unstructured":"Qureshi AI, Bains NK, Bhatti IA, Jani V, Suri MFK, Bhogal P. Intra-arterial lidocaine administration of lidocaine in middle meningeal artery for short-term treatment of subarachnoid hemorrhage-related headaches. Interv Neuroradiol. 2025:15910199241307049. https:\/\/doi.org\/10.1177\/15910199241307049.","DOI":"10.1177\/15910199241307049"},{"issue":"8","key":"1457_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0308800","volume":"19","author":"P Garc\u00eda-P\u00e9rez","year":"2024","unstructured":"Garc\u00eda-P\u00e9rez P, Rodr\u00edguez-Mart\u00ednez MC, Gallardo-Tur A, Blanco-Reina E, de la Cruz-Cosme C, Lara JP. Early occupational therapy intervention post-stroke (EOTIPS): a randomized controlled trial. PLoS One. 2024;19(8):e0308800.","journal-title":"PLoS One"},{"key":"1457_CR67","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.genhosppsych.2020.06.011","volume":"66","author":"GC Medeiros","year":"2020","unstructured":"Medeiros GC, Roy D, Kontos N, Beach SR. Post-stroke depression: a 2020 updated review. Gen Hosp Psychiatry. 2020;66:70\u201380. Cited 2025 Apr 20. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834320300955","journal-title":"Gen Hosp Psychiatry"},{"issue":"6","key":"1457_CR68","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1161\/STROKEAHA.118.023553","volume":"50","author":"SP Khot","year":"2019","unstructured":"Khot SP, Morgenstern LB. Sleep and stroke. Stroke. 2019;50(6):1612\u20137.","journal-title":"Stroke"},{"issue":"2","key":"1457_CR69","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1589\/jpts.31.149","volume":"31","author":"J Park","year":"2019","unstructured":"Park J. A study on the sleep quality, pain, and instrumental activities of daily living of outpatients with chronic stroke. J Phys Ther Sci. 2019;31(2):149\u201352.","journal-title":"J Phys Ther Sci"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01457-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01457-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01457-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T21:01:41Z","timestamp":1765314101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01457-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1457"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01457-z","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}